LATEST NEWS AND ARTICLES

From events, scientific articles to PR, you will find here all our latest news.

Why 3D human models will increasingly replace mice in drug testing & How do we make human 3D models not only more relevant — but also reproducible enough for decisions ?
Poietis, leading bioprinting company and Prometheus, Division of Skeletal Tissue Engineering at KU Leuven, entered into a 2-years Collaborative Research Agreement focused on high-precision 3D Bioprinting of tissue engineered Advanced Therapeutic Medicinal Products (ATMPs) for skeletal regeneration.
Poietis, a bioprinting leader, announces that it has closed a €5 million Series A financing round to accelerate technological developments that could lead to the first implantation of a bioprinted tissue into patients from 2021.

Do you want to know more about NGB platform?